Back to Search Start Over

Polymorphism in LEP and LEPR May Modify Leptin Levels and Represent Risk Factors for Thyroid Cancer

Authors :
Marjory Alana Marcello
Antonio Ramos Calixto
Jacqueline Fatima Martins de Almeida
Mariana Bonjiorno Martins
Lucas Leite Cunha
Camila Ayume Amano Cavalari
Elba C. S. Etchebehere
Ligia Vera Montalli da Assumpção
Bruno Geloneze
Andre Lopes Carvalho
Laura Sterian Ward
Source :
International Journal of Endocrinology, Vol 2015 (2015)
Publication Year :
2015
Publisher :
Hindawi Limited, 2015.

Abstract

Purpose. To understand the role of polymorphisms in the LEP (rs7799039 and rs2167270) and LEPR (rs1137101 and rs1137100) genes in DTC susceptibility and their effect on leptin levels. Methods. We studied 153 patients with DTC and 234 controls through TaqMan SNP Genotyping and ELISA, comparing these data to the clinicopathological data of patients with DTC. Results. Patients with AA genotype of rs7799039 had higher levels of serum leptin (9.22±0.98 ng/mL) than those with AG genotype (10.07±0.60 ng/mL; P=0.005). Individuals with AG genotype of rs2167270 also produced higher serum leptin levels (10.05±0.59 ng/mL) than the subjects with GG genotype (9.52±0.79 ng/mL; P

Details

Language :
English
ISSN :
16878337 and 16878345
Volume :
2015
Database :
Directory of Open Access Journals
Journal :
International Journal of Endocrinology
Publication Type :
Academic Journal
Accession number :
edsdoj.7b91a528f4514d19b6a1291d1f3d29cd
Document Type :
article
Full Text :
https://doi.org/10.1155/2015/173218